AZATHIOPRINE IN TYPE 1 LEPROSY REACTIONS-THE LEPROSY MISSION TRUST INDIA
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Leprosy Patients with Type 1 Reaction and neuritis
- Registration Number
- CTRI/2016/12/007558
- Lead Sponsor
- The Leprosy Mission Trust India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 345
Inclusion Criteria
Patients with acute neuritis ( <6months) with or without type 1 reactions or recurrenct reactional skin lesions
Exclusion Criteria
Wt. <30Kgs; confirmed pregnancy; Patients with treatment for TB, HIV-AIDS Hypertension, or Type2 reactions, Hepatic dysfunction, bonemarrow dysfunction, unable to comply with follow-up requirement.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recovery of nerve function and recurrence of neuritis during and after treatmentTimepoint: At entry, 3 months 6 months, 10.After completion of therapyeach patient will also be followed up at 60 weeks and at 72 weeks
- Secondary Outcome Measures
Name Time Method Recovery of nerve function and recurrence of neuritis during and after treatmentTimepoint: At entry, 3 months 6 months, 10.After completion of therapyeach patient will also be followed up at 60 weeks and at 72 weeks